venBio Select Advisor »

Revolution Medicines shares owned by venBio Select Advisor

Quarter-by-quarter ownership of Revolution Medicines (RVMD) shares owned by venBio Select Advisor from 13F filings

Historical chart of venBio Select Advisor investment in Revolution Medicines

Tip: Access up to 7 years of quarterly data

All positions including Revolution Medicines held by venBio Select Advisor consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revolution Medicines by venBio Select Advisor

Quarter filed Position value Share count Share price at filing
2025-12-31 $173M 2.2M 79.65
2020-06-30 $9.6M 304k 31.57
2020-03-31 $9.9M 450k 21.91

More positions owned by venBio Select Advisor

United Therapeutics Corp Common (UTHR)
Ascendis Pharma Sponsored ADR (ASND)
Madrigal Pharmaceuticals Common (MDGL)
Argenx Se Sponsored ADR (ARGX)
Krystal Biotech Common (KRYS)
Arrowhead Pharmaceuticals Common (ARWR)
Kymera Therapeutics Common (KYMR)
Structure Therapeutics Sponsored Ads (GPCR)
Avidity Biosciences Common (RNA)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Celcuity Common (CELC)
Apellis Pharmaceuticals Common (APLS)
Vera Therapeutics Common (VERA)
Spdr Series Trust - S&p Biotech Etf (XBI)
Xenon Pharmaceuticals Common (XENE)

View all positions for venBio Select Advisor

Top funds holding Revolution Medicines

Vanguard Group
Farallon Capital Management
Henderson Group
Wellington Management Company
Baker Bros. Advisors
FMR
BlackRock
Nextech Invest
Paradigm Biocapital Advisors
Bellevue Group
State Street Corporation
BVF
Alphabet
Geode Capital Management
UBS Group

View all funds holding Revolution Medicines